NIKKEI 225
29,100.38-584.99(-1.97%)HANG SENG
29,133.85+27.70(+0.10%)CRUDE OIL
64.08+0.70(+1.10%)
Adverum Biotechnologies, Inc. (0HA3.L)
| Previous close | 9.29 |
| Open | 9.10 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 9.10 - 9.10 |
| 52-week range | 9.10 - 9.10 |
| Volume | 100 |
| Avg. volume | N/A |
| Market cap | 473.5M |
| Beta (5Y monthly) | 1.46 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.38 |
| Earnings date | 26 May 2021 - 31 May 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
The Sonic Fund II, L.P. Files Definitive Proxy Statement and Sends Letter to Stockholders of Adverum Biotechnologies, Inc.
The Sonic Fund II, L.P. ("Sonic"), which beneficially owns approximately 6.8% of the outstanding common stock of Adverum Biotechnologies, Inc. (NASDAQ: ADVM) (the "Company" or "Adverum"), announced today that it has filed a definitive proxy statement and GREEN proxy card with the SEC in conjunction with the 2021 Annual Meeting of Stockholders (the "2021 Annual Meeting") that the Company is rushing to hold on May 12, 2021. Sonic has nominated three independent, highly qualified director candidates – Jean Bennett, Jodi Cook and Herbert Hughes (the "Nominees") – for election to the Adverum Board of Directors (the "Board") to serve until the 2024 Annual Meeting.
- Zacks
Is the Options Market Predicting a Spike in Adverum Biotechnologies (ADVM) Stock?
Investors need to pay close attention to Adverum Biotechnologies (ADVM) stock based on the movements in the options market lately.
- Motley Fool
Adverum Biotechnologies, Inc. (ADVM) Q4 2020 Earnings Call Transcript
ADVM earnings call for the period ending December 31, 2020.
